Lipoic Acid (13C5) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the anti-lipoic acid antibody (sc-101354) has been utilized in research contexts related to glioblastoma multiforme, as indicated in recent studies. It can be particularly useful for examining the role of lipoic acid in tumor biology and its potential implications in immunotherapy approaches.

The Lipoic Acid antibody is suitable for various applications, including Western Blotting, ELISA, Immunofluorescence, and Immunohistochemistry. These applications allow for the detection and analysis of lipoic acid in different sample types, which can be critical for understanding its biological functions.

While specific performance metrics are not provided, the antibody has been mentioned in the context of immunohistochemistry in scientific literature, suggesting its utility for visualizing lipoic acid in tissue samples, which can be essential for studying its localization and expression patterns in various biological contexts.

The Lipoic Acid antibody can be applied to a variety of sample types, including cell lines and tissue sections. This versatility makes it suitable for both in vitro and in vivo studies, allowing researchers to explore the role of lipoic acid across different biological systems.